On August 22, 2023, Immix Biopharma, Inc. closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.365 USD | +7.50% | +6.70% | -65.46% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.46% | 58.09M | |
-1.26% | 89.46B | |
+2.76% | 40.74B | |
-9.23% | 33.03B | |
+55.32% | 24.68B | |
-16.74% | 15.12B | |
-8.95% | 12.81B | |
-12.11% | 11.79B | |
-43.61% | 11.64B | |
+7.79% | 8.9B |
- Stock Market
- Equities
- IMMX Stock
- News Immix Biopharma, Inc.
- Immix Biopharma, Inc. announced that it has received $9.999998 million in funding